Roche

FDA headquarters
#Duchenne muscular dystrophy #FDA #Gene therapy #Roche #Sarepta Therapeutics

FDA expands gene therapy use in Duchenne muscular dystrophy

The US Food and Drug Administration (FDA) has expanded its approval for Elevidys (delandistrogene moxeparvovec-rokl) to include individuals with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are at least four years of age. Confirming the functional benefits, the FDA granted traditional approval for ambulatory… Read More

#News #Regulatory

Digital technology concept
#Clarivate #Johnson & Johnson #Roche

Roche and Johnson & Johnson make global innovators list

Roche and Johnson & Johnson are the only pharma companies to feature in Clarivate’s 2024 list of Top 100 Global Innovators, which highlights organisations leading the world in technology research and innovation. This is the first year that Clarivate is ranking, rather than just listing, the top innovators. Johnson &… Read More

#Business & Investment #News

Petri dish used for bacterial research
#AMR #Antibiotic resistance #Antibiotics #Harvard Medical School #Roche

Excitement over new antibiotics that can kill drug-resistant bacteria

A novel antibiotic class targeting a major global pathogen and threat to human health has been discovered by scientists from Roche and Harvard University (Cambridge, MA, US). In two studies published in Nature, the authors demonstrate that the new class of drug candidates can effectively target… Read More

#News #Trending News

Lung cancer
#Cancer research #Immunotherapy #Lung cancer #Oncology #Roche #University College London

Immunotherapy improves lung cancer long-term survival

A global study, led by University College London (UCL) and University College London Hospitals (UCLH) and sponsored by Roche, has shown that the cancer immunotherapy atezolizumab significantly improved the overall survival of advanced stage non-small cell lung cancer (NSCLC) patients, when compared to single-agent chemotherapy. For… Read More

#Cancer Research #News

#ABL Diagnostics #Collaboration #Cytomegalovirus #Diagnostics #HIV #Human Papillomavirus #Infectious diseases #Laboratory #Microbiology #Roche #Tuberculosis #Viral hepatitis

Roche and ABL Diagnostics expand to South African laboratories  

Roche Diagnostics and ABL Diagnostics have launched a distribution partnership which will see Roche supplying ABLD products to South African laboratories.   Roche now has exclusive rights to distribute products, including the ABL DeepChek assays to laboratories implementing microbiology applications. These applications include HIV, Tuberculosis, Cytomegalovirus, Viral… Read More

#News

#Drug discovery #Pharmaceutical industry #Phenotyping #PhoreMost #Roche

PhoreMost and Roche enter drug discovery partnership

Roche and UK-based biopharmaceutical company PhoreMost have agreed to a multi-project target discovery collaboration. Under the terms of the agreement, PhoreMost will receive an upfront payment and is eligible for preclinical success-based milestones. PhoreMost will deploy its phenotypic screening platform, SITESEEKER, toward disease-relevant pathways nominated by Roche. Novel targets identified… Read More

#Business & Investment #News